{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:57:34Z","timestamp":1768611454762,"version":"3.49.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cold agglutinin syndrome (CAS) is a form of autoimmune hemolytic anemia (AIHA), most often associated with lymphoproliferative disorders or infections. Its occurrence in breast cancer is rare and may be triggered by systemic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of a woman in their fifties diagnosed with breast cancer in 2019. She underwent surgery followed by adjuvant chemotherapy and radiotherapy and subsequently received 3 years of endocrine therapy before developing bone and hepatic metastases. First-line treatment with ribociclib plus letrozole achieved partial response, and fulvestrant was administered at progression. Following further progression, paclitaxel was introduced as third-line metastatic therapy. After four weekly administrations, the patient was admitted to our hospital with severe anemia and diagnosed with CAS. Prompt management and a multidisciplinary approach resulted in partial hematological recovery. Nevertheless, paclitaxel was permanently discontinued, and subsequent therapies provided only transient benefit. The disease continued to progress, her performance status declined, and she ultimately transitioned to exclusive palliative care until death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case illustrates a rare and severe immune complication of paclitaxel in metastatic breast cancer. The emergence of CAS not only limited systemic options but also reshaped the therapeutic trajectory, highlighting the need for close monitoring during cancer treatments. Early recognition, multidisciplinary approach, and prompt management can provide some improvement, although overall prognosis remains determined by the underlying malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1711809","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:31:41Z","timestamp":1768577501000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cold agglutinin syndrome in a patient with metastatic breast cancer: a Case Report"],"prefix":"10.3389","volume":"12","author":[{"given":"Daniel","family":"Bandarra","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, ULS do Algarve","place":["Faro, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Rochate","sequence":"additional","affiliation":[{"name":"Department of Medical Hematology, ULS do Algarve","place":["Faro, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Gosalbez","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, ULS do Algarve","place":["Faro, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, ULS do Algarve","place":["Faro, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidia Maltez","family":"Cunha","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, ULS do Algarve","place":["Faro, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Carvalhal","sequence":"additional","affiliation":[{"name":"Algarve Biomedical Center, Research institute (ABC-Ri), Universidade do Algarve","place":["Faro, Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9347","DOI":"10.1038\/s41598-025-93883-9","article-title":"The global burden of breast cancer among women of reproductive age: a comprehensive analysis | Scientific Reports.","volume":"15","author":"Cai","year":"2025","journal-title":"Sci Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12964-023-01145-w","article-title":"Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy.","volume":"21","author":"Yuan","year":"2023","journal-title":"Cell Commun Signal."},{"key":"B3","first-page":"35","article-title":"Cold agglutinin disease: where do we stand, and where are we going?","volume":"18","author":"Berentsen","year":"2020","journal-title":"Clin Adv Hematol Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1182\/blood.2019003809","article-title":"How I treat cold agglutinin disease.","volume":"137","author":"Berentsen","year":"2021","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting.","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e74437","DOI":"10.7759\/cureus.74437","article-title":"Breast adenocarcinoma and cold agglutinin disease: a paraneoplastic syndrome.","volume":"16","author":"Honore","year":"2024","journal-title":"Cureus."},{"key":"B7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4274\/tjh.2014.0373","article-title":"An unusual presentation of metastatic breast carcinoma as cold autoimmune hemolytic anemia.","volume":"32","author":"Chellappan","year":"2015","journal-title":"Turk J Haematol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/20009666.2019.1698262","article-title":"Cold autoimmune hemolytic anemia: a rare association with triple-positive breast cancer.","volume":"9","author":"Tauseef","year":"2019","journal-title":"J Community Hosp Intern Med Perspect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1111\/trf.13255","article-title":"Drug-induced immune hemolytic anemia associated with anti-carboplatin and the first example of anti-paclitaxel.","volume":"55","author":"Leger","year":"2015","journal-title":"Transfusion."},{"key":"B10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/17474086.2024.2366540","article-title":"The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease.","volume":"17","author":"Barcellini","year":"2024","journal-title":"Expert Rev Hematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"003740","DOI":"10.12890\/2023_003740","article-title":"rare cause of recurrent haemolytic anaemia: carboplatin and paclitaxel-induced autoimmune haemolytic anaemia.","volume":"10","author":"Yingchoncharoen","year":"2023","journal-title":"Eur J Case Rep Intern Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.blre.2012.01.002","article-title":"Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.","volume":"26","author":"Berentsen","year":"2012","journal-title":"Blood Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1182\/blood-2017-04-778175","article-title":"Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.","volume":"130","author":"Berentsen","year":"2017","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e924283","DOI":"10.12659\/AJCR.924283","article-title":"Pembrolizumab-induced cold agglutinin disease.","volume":"21","author":"Atiq","year":"2020","journal-title":"Am J Case Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fimmu.2020.00590","article-title":"New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia.","volume":"11","author":"Berentsen","year":"2020","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1182\/asheducation-2016.1.226","article-title":"Cold agglutinin disease.","volume":"2016","author":"Berentsen","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.3390\/jcm9124034","article-title":"Rituximab use in warm and cold autoimmune hemolytic anemia.","volume":"9","author":"Murakhovskaya","year":"2020","journal-title":"J Clin Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1182\/blood-2003-10-3597","article-title":"Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients.","volume":"103","author":"Berentsen","year":"2004","journal-title":"Blood."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1711809\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:31:42Z","timestamp":1768577502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1711809\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":18,"alternative-id":["10.3389\/fmed.2025.1711809"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1711809","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"1711809"}}